- Home
- SSL vs SUPN Comparison
SSL vs SUPN Comparison
Compare SSL & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSL
- SUPN
- Stock Information
- Founded
- SSL 1950
- SUPN 2005
- Country
- SSL South Africa
- SUPN United States
- Employees
- SSL N/A
- SUPN N/A
- Industry
- SSL Oil & Gas Production
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- SSL Energy
- SUPN Health Care
- Exchange
- SSL Nasdaq
- SUPN Nasdaq
- Market Cap
- SSL 2.1B
- SUPN 1.7B
- IPO Year
- SSL N/A
- SUPN 2012
- Fundamental
- Price
- SSL $3.51
- SUPN $31.37
- Analyst Decision
- SSL
- SUPN Hold
- Analyst Count
- SSL 0
- SUPN 2
- Target Price
- SSL N/A
- SUPN $36.00
- AVG Volume (30 Days)
- SSL 1.6M
- SUPN 548.0K
- Earning Date
- SSL 01-01-0001
- SUPN 05-07-2025
- Dividend Yield
- SSL N/A
- SUPN N/A
- EPS Growth
- SSL N/A
- SUPN 6500.00
- EPS
- SSL N/A
- SUPN 1.32
- Revenue
- SSL $13,819,021,376.00
- SUPN $661,817,000.00
- Revenue This Year
- SSL N/A
- SUPN N/A
- Revenue Next Year
- SSL $5.80
- SUPN $9.32
- P/E Ratio
- SSL N/A
- SUPN $23.61
- Revenue Growth
- SSL N/A
- SUPN 8.94
- 52 Week Low
- SSL $2.78
- SUPN $25.53
- 52 Week High
- SSL $8.40
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- SSL 43.62
- SUPN 42.43
- Support Level
- SSL $3.44
- SUPN $29.87
- Resistance Level
- SSL $3.68
- SUPN $31.70
- Average True Range (ATR)
- SSL 0.17
- SUPN 1.46
- MACD
- SSL 0.05
- SUPN -0.03
- Stochastic Oscillator
- SSL 80.56
- SUPN 23.83
About SSL Sasol Ltd.
Sasol Ltd operates as a vertically integrated chemicals and energy company through its two main segments: Energy business and Chemical business. It generates maximum revenue from the Chemicals segment. The company operates coal mines and its upstream interests in oil and gas, both of which are used as feedstock in the company's energy and chemicals operations. Sasol markets commodity and performance chemicals, sells liquid fuel products, and markets, distributes and transports pipeline gas. Geographically the company generates the majority of its revenue from South Africa.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.